Regentis Biomaterials Ltd. (RGNT)Healthcare | Medical Instruments & Supplies | Herzliya, Israel | NYSE American
3.05 USD
-0.15
(-4.688%) ⇩
(April 17, 2026, 3:55 p.m.
EDT)
Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 1:37 p.m. EDT
RGNT is currently in a volatile and downward trend, with a recent price drop and negative earnings. The short-term forecasting model predicts a significant decline, which suggests caution for short-term traders. The stock's low market cap and high debt-to-equity ratio indicate financial instability, making it a risky long-term investment. Additionally, there are no dividend payouts, which further reduces its appeal for income-focused investors. Overall, this stock is not recommended for either short-term or long-term investment at this time. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.561484 |
| MSTL | 0.584131 |
| AutoTheta | 0.600156 |
| AutoETS | 0.602023 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 42% |
| H-stat | 8.39 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.043 |
| Excess Kurtosis | -0.70 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 25.232 |
| Market Cap | 15,797,103 |
| Website | https://www.regentis.co.il |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.59333336 |
| Address1 | 60, Medinat Hayehudim |
| Address2 | Entrance C Herzlia Pituach |
| All Time High | 8.35 |
| All Time Low | 2.8 |
| Ask | 3.45 |
| Ask Size | 300 |
| Average Daily Volume10 Day | 4,030 |
| Average Daily Volume3 Month | 11,504 |
| Average Volume | 11,504 |
| Average Volume10Days | 4,030 |
| Bid | 2.92 |
| Bid Size | 100 |
| Book Value | 0.916 |
| City | Herzliya |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Israel |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 3.05 |
| Current Ratio | 2.651 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 3.29 |
| Day Low | 2.9501 |
| Debt To Equity | 25.232 |
| Display Name | Regentis Biomaterials |
| Ebitda Margins | 0.0 |
| Enterprise Value | 9,616,103 |
| Eps Current Year | -0.68 |
| Eps Trailing Twelve Months | -24.16 |
| Esg Populated | 0 |
| Exchange | ASE |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 3.51542 |
| Fifty Day Average Change | -0.46542 |
| Fifty Day Average Change Percent | -0.13239385 |
| Fifty Two Week Change Percent | -59.333336 |
| Fifty Two Week High | 8.35 |
| Fifty Two Week High Change | -5.3 |
| Fifty Two Week High Change Percent | -0.6347305 |
| Fifty Two Week Low | 2.8 |
| Fifty Two Week Low Change | 0.25 |
| Fifty Two Week Low Change Percent | 0.08928572 |
| Fifty Two Week Range | 2.8 - 8.35 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,764,858,600,000 |
| Float Shares | 2,997,617 |
| Free Cashflow | 3,029,625 |
| Full Exchange Name | NYSE American |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.19047001 |
| Held Percent Institutions | 0.23261 |
| Implied Shares Outstanding | 5,179,378 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is based in Herzliya, Israel. |
| Long Name | Regentis Biomaterials Ltd. |
| Market | us_market |
| Market Cap | 15,797,103 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_13190555 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -13,692,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 15,797,102 |
| Number Of Analyst Opinions | 1 |
| Open | 3.29 |
| Operating Cashflow | -1,375,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 972 9 960 1917 |
| Previous Close | 3.2 |
| Price Eps Current Year | -4.485294 |
| Price Hint | 4 |
| Price To Book | 3.3296943 |
| Profit Margins | 0.0 |
| Quick Ratio | 2.647 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.15 |
| Regular Market Change Percent | -4.6875 |
| Regular Market Day High | 3.29 |
| Regular Market Day Low | 2.9501 |
| Regular Market Day Range | 2.9501 - 3.29 |
| Regular Market Open | 3.29 |
| Regular Market Previous Close | 3.2 |
| Regular Market Price | 3.05 |
| Regular Market Time | 1,776,455,719 |
| Regular Market Volume | 2,577 |
| Return On Assets | -1.07531 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 5,179,378 |
| Shares Percent Shares Out | 0.0029 |
| Shares Short | 14,765 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 26,985 |
| Short Name | Regentis Biomaterials Ltd. |
| Short Percent Of Float | 0.0045 |
| Short Ratio | 2.74 |
| Source Interval | 15 |
| Symbol | RGNT |
| Target High Price | 10.0 |
| Target Low Price | 10.0 |
| Target Mean Price | 10.0 |
| Target Median Price | 10.0 |
| Total Cash | 7,378,000 |
| Total Cash Per Share | 1.424 |
| Total Debt | 1,197,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -24.16 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 4.9805 |
| Two Hundred Day Average Change | -1.9305003 |
| Two Hundred Day Average Change Percent | -0.38761172 |
| Type Disp | Equity |
| Volume | 2,577 |
| Website | https://www.regentis.co.il |
| Zip | 4,676,652 |